Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 221-240 of 1,334 trials

Neurostimulation to Improve NOWS Outcomes

NCT05129020

The objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatment.

Neonatal Opioid Withdrawal SyndromeNeonatal Abstinence Syndrome

Spark Biomedical, Inc.52 participantsStarted Jul 2022

Charleston, South Carolina, United States • Dallas, Texas, United States • San Antonio, Texas, United States

RECRUITINGPHASE3< 1 mile

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

NCT06651281

Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who received tulisokibart in certain other studies for CD or UC (called a parent study) may be able to join this study. The goals of this study are to learn about the safety of tulisokibart over time in people with CD or UC, and if people tolerate it.

Crohn DiseaseColitis, Ulcerative

Merck Sharp & Dohme LLC1,380 participantsStarted Nov 2024

Bristol, Connecticut, United States • Ypsilanti, Michigan, United States • Liberty, Missouri, United States +34 more locations

Neurostimulation to Improve NOWS Outcomes

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Rheumatoid Arthritis Trials in Other Cities

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Ribociclib and Letrozole Treatment in Ovarian Cancer

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

SP Thoracic IDE Study

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

PRO-232 in Patients Subjected to Cataract Surgery

Acute Hip Fracture Study in Patients 65 Years or Greater

Other Conditions in San Antonio